Research Pipeline

Research & Development

Our R&D engine has both internal research capabilities and external partnerships is expected to deliver a steady stream of next-generation developments that will sustain our growth. These programs leverage new platform capabilities in multi-omics, data sciences, and more.

As you can see from our current research pipeline, there’s a lot happening behind the scenes at TruDiagnostic — and a lot to look forward to.

Our Research Timeline

Active Studies

Estimated Completion Date: August 2021 

Principle Investigator: Dr. Edwin Lee, MD

Estimated Completion Date: August 2021 

Principle Investigator: Dr. Hector Lopez, MD, CSCS, FAAPMR

Estimated Completion Date: December 2021 

Principle Investigator: Dr. Tavis Mendez, PhD

Estimated Completion Date: December 2021 

Principle Investigator: Dr. Tavis Mendez, PhD

> Read More About This Project <

Estimated Completion Date: September 2022

Principle Investigator: Dr. Jessica Lasky-Su

Estimated Completion Date: June 2022

Principle Investigator: Dr. Vincent Giampapa MD, FACS

Estimated Completion Date: November 2022

Principle Investigator: Dr. Tavis Mendez, Ph.D.

Estimated Completion Date: July 2022

Principle Investigator: Dr. Anthony Maffei

Estimated Completion Date: December 2021 

Principle Investigator: Dr. Julie Kissel, MD

Study Sponsor: QuickSilver 

Estimated Completion Date: June 2022 

Principle Investigator: Dr. Sanjeev Goel, MD

Study Sponsor:  TruDiagnostic LLC, Peak Human Labs

Estimated Completion Date: August 2021 

Principle Investigator: Dr. Tavis Mendez, PhD

Study Sponsor: TruDiagnostic LLC

Estimated Completion Date: November 2021 

Principle Investigator: Dr. James Foster

Study Sponsor: Preventative Medicine Research Group

Estimated Completion Date: March 2022 

Principle Investigator: Dr. Phillip Gallegos, MD

Study Sponsor:  Optigenex, Inc.

Estimated Completion Date: February 2022 

Principle Investigator:  Dr. Juergen Winkler, MD

Study Sponsor: Extended Longevity. Inc.